Abstract

Through some markets are relatively free of profit-blocking restrictions, most markets impose strong barriers to the introduction of genetically genetically engineered crops and foodstuffs. Agrochemical firms that have invested significant resources in biotechnology applications encounter varying degrees of market access and acceptance. Some external stakeholders remain skeptical of the technology, with their refusal to accept in hurting innovators' returns on investment. We explore the tension between the social rationality perspective and the scientific rationality perspective on this issue. Critically evaluating the benefits of each perspective to innovation efforts we make several theoretical and practical recommendations.

Publication Date

2007

Comments

ISSN:1553-9563 Note: imported from RIT’s Digital Media Library running on DSpace to RIT Scholar Works in February 2014.

Document Type

Article

Department, Program, or Center

Accounting (SCB)

Campus

RIT – Main Campus

Share

COinS